Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05288907 · ClinicalTrials.gov registry record
SOOTHER Trial to Treat Rectal Itch
A clinical trial of Pruritus Ani, sponsored by Bell International Laboratories.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05288907: Completed study of Pruritus Ani, sponsored by Bell International Laboratories.
NCT05288907 is a study of Pruritus Ani that has completed, run by Bell International Laboratories. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05288907, a study of Pruritus Ani, has completed, sponsored by Bell International Laboratories.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Longitudinal, observational, single-arm trial of a novel, composite Lidocaine ointment to treat rectal itch (pruritus ani)
Primary Outcome
SOOTHER Symptom assessment at 2 weeks rated on a 5-point analog scale, with 5 being the worst
Conditions Studied
Interventions
- DRUG Lidocaine Ointment
Study Locations (1)
Minnesota
- Minnesota Gastroenterology - Plymouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2021-12-10 |
What the finished NCT05288907 record still lists
NCT05288907 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Pruritus Ani appearing as the primary indexed condition, and to 1 intervention - of which Lidocaine Ointment is the first listed.
NCT05288907 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05288907 about?
NCT05288907 is a clinical study titled "SOOTHER Trial to Treat Rectal Itch". Longitudinal, observational, single-arm trial of a novel, composite Lidocaine ointment to treat rectal itch (pruritus ani)
What is the current status of trial NCT05288907?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-09-01. Estimated completion is 2021-12-10.
What conditions does trial NCT05288907 study?
This clinical trial studies the following conditions: Pruritus Ani.
What interventions are being tested in trial NCT05288907?
The interventions under investigation include: Lidocaine Ointment (DRUG).
Who is sponsoring clinical trial NCT05288907?
This trial is sponsored by Bell International Laboratories, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05288907 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI